Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis

被引:29
作者
Kenngott, S
Gerbes, AL
Schauer, R
Bilzer, M
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Dept Surg, D-8000 Munich, Germany
关键词
alcohol-induced cirrhosis; De novo malignancy; esophageal and oropharyngeal squamous cell carcinoma; immunosuppression; liver transplantation;
D O I
10.1007/s00147-003-0600-8
中图分类号
R61 [外科手术学];
学科分类号
摘要
Liver transplant recipients have an increased risk of developing de novo malignancies. It is generally accepted that chronic alcohol abuse is a contributive factor in the pathogenesis of several malignancies, in particular, of oropharyngeal squamous cell carcinoma (SCC). Thus, patients with end-stage alcohol-induced cirrhosis could be at risk of esophageal SCC following orthotopic liver transplantation (OLT). From January 1986 to December 1997 a total of 313 patients underwent OLT for various indications. Of these patients, 72 had alcohol-related cirrhosis. Oropharyngeal and esophageal malignancies after OLT were not observed in non-alcoholic patients. In contrast, these malignancies were diagnosed in three male patients who underwent transplantation for alcohol-induced cirrhosis (incidence 4.2%). Furthermore, all patients had a history of tobacco abuse. The tumors were located in the tongue of one patient and in the esophagus of two patients. While SCC of the tongue became apparent 5 years after OLT, esophageal SCC was detected 8 and 16 months after transplantation. Shortly before transplantation, endoscopy of the esophagus had not revealed evidence of pre-malignant dysplastic lesions in any of these patients. Thus, esophageal SCC may develop rapidly in patients undergoing transplantation for alcohol-related cirrhosis with a history of tobacco abuse before liver transplantation, which warrants careful post-transplant screening of these patients.
引用
收藏
页码:639 / 641
页数:3
相关论文
共 17 条
  • [1] Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
    Dantal, J
    Hourmant, M
    Cantarovich, D
    Giral, M
    Blancho, G
    Dreno, B
    Soulillou, JP
    [J]. LANCET, 1998, 351 (9103) : 623 - 628
  • [2] Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis
    Duvoux, C
    Delacroix, I
    Richardet, JP
    Roudot-Thoraval, F
    Métreau, JM
    Fagniez, PL
    Dhumeaux, D
    Cherqui, D
    [J]. TRANSPLANTATION, 1999, 67 (03) : 418 - 421
  • [3] GASTROINTESTINAL CARCINOMAS IN RENAL-TRANSPLANT RECIPIENTS
    FECZKO, PJ
    MEZWA, DG
    [J]. GASTROINTESTINAL RADIOLOGY, 1991, 16 (04): : 351 - 353
  • [4] Frezza EE, 1997, HEPATO-GASTROENTEROL, V44, P1172
  • [5] Increased cancer risk after liver transplantation: a population-based study
    Haagsma, EB
    Hagens, VE
    Schaapveld, M
    van den Berg, AP
    de Vries, EGE
    Klompmaker, IJ
    Slooff, MJH
    Jansen, PLM
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 84 - 91
  • [6] Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation
    Hézode, C
    Duvoux, C
    Germanidis, G
    Roudot-Thoraval, F
    Vincens, AL
    Gaulard, P
    Cherqui, D
    Pawlotsky, JM
    Dhumeaux, D
    [J]. HEPATOLOGY, 1999, 30 (03) : 775 - 778
  • [7] Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
    Jain, AB
    Yee, LD
    Nalesnik, MA
    Youk, A
    Marsh, G
    Reyes, J
    Zak, M
    Rakela, J
    Irish, W
    Fung, JJ
    [J]. TRANSPLANTATION, 1998, 66 (09) : 1193 - 1200
  • [8] Jonas S, 1997, CANCER, V80, P1141, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO
  • [9] 2-8
  • [10] LEVY M, 1993, TRANSPLANT P, V25, P1397